Company intro: Genpharm is a financially sound privately-owned company based in the Dubai Science Park (DSP), U.A.E. A specialty pharmaceutical company providing partners with fast-track market access and sustainable commercial solutions into the Middle East and North Africa (MENA) region and Turkey. We are the preferred regional commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics. We are the first organization to introduce gene therapy in the MENAT Region. We also provide strategic advice on disease areas, product launches, and go to markets strategies. We operate through evidence-based medicine and at the highest ethical standards. Genpharm is driven by a clear purpose. Our employees, associates, and partners take this to heart. It is apparent in our daily work, in every interaction within our communities and with every partnership we forge. We are #BringingCuresToMENATPatients.
HVD Life Sciences is a marketing & distribution company that specializes in lifescience solutions in the field of Allergy, Autoimmunity, Newborn Screening & SCID. We partner with industry leading manufacturers like ThermoFisher Phadia & Revvity to offer wide range of high-quality products. With extensive branch offices we cover regions including Middle East, Africa, Europe and Far East.
As one of Qatar’s leading healthcare solution providers, MedTech has consistently pushed the envelope when it comes to our offerings and service. The last forty years tell a story of how our success has been scripted by our core values and relentless pursuit of innovation. We render our services and supply world-class equipment to government and healthcare institutions across Qatar and the Middle East.
Biotest is a provider of biological medicinal products derived from human plasma. With a value chain that extends from preclinical and clinical development to worldwide marketing, Biotest specializes primarily in the fields of clinical immunology, haematology and intensive care and emergency medicine. Biotest develops and markets immunoglobulins, coagulation factors and albumin, which are produced on the basis of human blood plasma and are used to treat diseases of the immune system or the hematopoietic system. Biotest employs more than 2,400 people worldwide. The ordinary and preference shares of Biotest AG are listed in the Prime Standard of the German Stock Exchange. Since May 2022, Biotest has been part of the Grifols Group, Barcelona, Spain (www.grifols.com).
Hikma is a multinational pharmaceutical company that was founded over 45 years ago. The company is listed on the London Stock Exchange and is known as a global company with a local presence across North America, MENA and Europe, providing customers with a broad range of generic, specialty and branded pharmaceutical products.
Hikma puts better health within reach, every day. Through the creation of high-quality products and ensuring their accessibility to those in need, in hikma, we aim to contribute to building a healthier world that benefits all our communities.
https://www.chiesirarediseases.com
Chiesi Global Rare Diseases is a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases. As a family business, Chiesi Group strives to create a world where it is common to have a therapy for all diseases and acts as a force for good, for society and the planet. The goal of the Global Rare Diseases unit is to ensure equal access so as many people as possible can experience their most fulfilling life. The unit collaborates with the rare disease community around the globe to bring voice to underserved people in the health care system.
For more information visit www.chiesirarediseases.com.
JMF is a global nonprofit dedicated to early diagnosis, treatments, and ultimately, future cures for Primary Immunodeficiency through awareness, advocacy, and research.